EBV Ab to Viral Capsid Antigen, IgG




Test Mnemonic

EBVG

CPT Codes

  • 86665 - QTY (1)

LOINC ®

7885-7

Aliases

  • Epstein Barr Virus Ab to Viral Capsid Ag, IgG

Performing Laboratory

Cleveland Clinic Laboratories


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLSerumSST (Gold) Refrigerated 

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
0.5 mL     

Stability

Environmental Condition Description
Ambient24 hours
Refrigerated7 days
Frozen14 days

Days Performed

Sun - Fri

Turnaround Time

1 - 2 days

Methodology

Name Description
Chemiluminescence Immunoassay (CLIA) 

Reference Range

EBV Ab to Viral Capsid Antigen, IgG
Sex Age From Age To Type Range Range Unit
       NormalRefer to reportU/mL

Special Info

Avoid hemolysis. Avoid multiple freeze thaw cycles.

Clinical Info

The test is used to investigate the evidence of recent or past EBV infection.

Clinical Limitation

Assay performance has not been established for immunocompromised or immunosuppressed patients. Assay performance has not been established for cord blood, neonatal specimens or infants. There is a possibility of assay cross-reactivity with specimens containing anti E-coli antibody. Assay performance has not been established for the diagnosis of nasopharyngeal carcinoma, Burkitt's lymphoma, other EBV-associated lymphomas, and other EBV associated diseases other than EBV related mononucleosis. Testing should not be performed as a screening procedure for the general population. It should only be performed when clinical evidence suggests the diagnosis of EBV-associated infectious mononucleosis. If the marker is negative and exposure to EBV is suspected, a second sample should be collected and tested no less than one-two weeks later. In cases of equivocal results, a second freshly collected sample should be obtained and tested.